Lyra Therapeutics, Inc. (LYRA)
NASDAQ: LYRA · IEX Real-Time Price · USD
5.39
-0.02 (-0.28%)
Apr 18, 2024, 4:00 PM EDT - Market closed
Lyra Therapeutics Market Cap
Lyra Therapeutics has a market cap or net worth of $322.02 million as of April 18, 2024. Its market cap has increased by 304.54% in one year.
Market Cap
322.02M
Enterprise Value
244.75M
1-Year Change
304.54%
Ranking
Category
Stock Price
$5.39
Market Cap Chart
Since May 1, 2020, Lyra Therapeutics's market cap has increased from $229.70M to $322.02M, an increase of 40.19%. That is a compound annual growth rate of 8.90%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 17, 2024 | 322.90M | 0.09% |
Apr 16, 2024 | 322.60M | 2.48% |
Apr 15, 2024 | 314.80M | -0.19% |
Apr 12, 2024 | 315.40M | -2.95% |
Apr 11, 2024 | 325.00M | 3.60% |
Apr 10, 2024 | 313.70M | 0.19% |
Apr 9, 2024 | 313.10M | 2.76% |
Apr 8, 2024 | 304.70M | 1.60% |
Apr 5, 2024 | 299.90M | -4.91% |
Apr 4, 2024 | 315.40M | -3.31% |
Apr 3, 2024 | 326.20M | -2.68% |
Apr 2, 2024 | 335.20M | -10.23% |
Apr 1, 2024 | 373.40M | 0.48% |
Mar 28, 2024 | 371.60M | -4.74% |
Mar 27, 2024 | 390.10M | 6.53% |
Mar 26, 2024 | 366.20M | -0.49% |
Mar 25, 2024 | 368.00M | -1.29% |
Mar 22, 2024 | 372.80M | 16.83% |
Mar 21, 2024 | 319.10M | - |
Mar 20, 2024 | 319.10M | 0.50% |
Mar 19, 2024 | 317.50M | 4.68% |
Mar 18, 2024 | 303.30M | -2.69% |
Mar 15, 2024 | 311.70M | 3.49% |
Mar 14, 2024 | 301.20M | -10.60% |
Mar 13, 2024 | 336.90M | 3.53% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Tactile Systems Technology | 335.96M |
Health Catalyst | 333.52M |
Renovaro Biosciences | 330.44M |
Precigen | 328.57M |
Acrivon Therapeutics | 325.39M |
CVRx, Inc. | 319.36M |
Esperion Therapeutics | 318.68M |
MeiraGTx Holdings | 318.62M |